Amentoflavone Inhibits Hepatocellular Carcinoma Progression Through Blockage of ERK/NF-ĸB Activation

Aim: The aim of the present study was to confirm therapeutic efficacy and find probable mechanism of action of amentoflavone in hepatocellular carcinoma (HCC) in vivo. Materials and Methods: Luciferase reporter vector pGL4.50_transfected SK-Hep1 (SK-Hep1/luc2) tumor-bearing mice were treated with ve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:In Vivo
Main Authors: LEE, KUN-CHING, CHEN, WEI-TING, LIU, YU-CHANG, LIN, SONG-SHEI, HSU, FEI-TING
Formato: Artigo
Idioma:Inglês
Publicado em: International Institute of Anticancer Research 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199595/
https://ncbi.nlm.nih.gov/pubmed/30150431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11351
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados